Arca
Skip to content
Tools
Tools

SLC29A1: Equilibrative nucleoside transporter 1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Uniporter involved in the facilitative transport of nucleosides and nucleobases, and contributes to maintaining their cellular homeostasis.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who Is On It, and How Far Along

Every drug ChEMBL records acting on SLC29A1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved1

  • Dipyridamole

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionMechanismOpen trialsWarnings
        DipyridamoleApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeInhibitorEquilibrative nucleoside transporter 1 inhibitor12—

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Non-Invasive Coronary Functional Evaluation of Patients With Single-vessel Coronary Artery DiseaseDipyridamoleNot applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS2026-09-04
        Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological EffectsDipyridamolePhase 1 / Phase 2Not yet recruitingHadassah Medical Organization2026-07-31
        Non-invasive Evaluation of Patients With Angina and Non-obstructive Coronary Artery DiseaseDipyridamoleNot applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS2026-02-20
        A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With DipyridamoleDipyridamolePhase 2 / Phase 3RecruitingYunfeng Xia2025-09-30
        Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale StudyDipyridamole—Not yet recruitingNational University Hospital, Singapore2025-05-21
        Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery StenosisDipyridamoleNot applicableRecruitingBeijing Tiantan Hospital2025-03-28
        Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant RecipientsDipyridamolePhase 2RecruitingStanford University2025-02-13
        Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTADipyridamoleNot applicableRecruitingSemmelweis University2024-11-01

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Coronary artery disorder
        0.54
        Stroke disorder
        0.54
        Hypertensive disorder
        0.37
        Recurrent thrombophlebitis
        0.37
        Fetal erythroblastosis
        0.33
        Transient ischemic attack
        0.32
        Cervical artery dissection
        0.26
        Urinary bladder carcinoma
        0.19

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1997, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q99808, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.